These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6956764)

  • 21. Specific tumor immunity induced with mitomycin C-treated syngeneic tumor cells (MCT). Effects of carrageenan and trypan blue on MCT-induced immunity in mice.
    Wu RL; Kearney R
    J Natl Cancer Inst; 1980 Jan; 64(1):81-7. PubMed ID: 6928050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of macrophage antitumor activity by a mycobacterial fraction. In vivo and in vitro studies.
    Rashid G; Gittel H; Ben-Efraim S
    Anticancer Res; 1994; 14(3A):1083-7. PubMed ID: 8074454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
    Schorlemmer HU; Bosslet K; Sedlacek HH
    Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumoricidal effector mechanisms of murine BCG-activated macrophages. I. Parameters of production and initial characterization of a cytolytic factor serologically related to necrosin.
    Klostergaard J; Foster WA; Leroux ME
    J Biol Response Mod; 1987 Jun; 6(3):313-30. PubMed ID: 3298554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonselective destruction of murine neoplastic cells by syngeneic tumoricidal macrophages.
    Fogler WE; Fidler IJ
    Cancer Res; 1985 Jan; 45(1):14-8. PubMed ID: 3855280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo modulation of macrophage tumoricidal activity: enhanced tumor cell killing by peritoneal macrophages from mice given injections of sodium periodate.
    Weinberg JB
    J Natl Cancer Inst; 1981 Mar; 66(3):529-33. PubMed ID: 6259399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ontogeny of 'macrophage' function. IV. Newborn mouse macrophages strongly suppress tumour cell growth and readily acquire cytolytic activity in comparison with adult macrophages.
    Ido M; Uno K; Inaba K; Aotsuka Y; Muramatsu S
    Immunology; 1984 Jun; 52(2):307-17. PubMed ID: 6735438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipopolysaccharide-mediated macrophage activation: the role of calcium in the generation of tumoricidal activity.
    Drysdale BE; Yapundich RA; Shin ML; Shin HS
    J Immunol; 1987 Feb; 138(3):951-6. PubMed ID: 3100622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction by heterologous fibrinogen of release of TNF-like cytotoxic factor from murine macrophages.
    Kajikawa T; Oshima H; Yamazaki M; Mizuno D
    J Biol Response Mod; 1986 Aug; 5(4):283-7. PubMed ID: 3525763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colchicine down-regulates lipopolysaccharide-induced granulocyte-macrophage colony-stimulating factor production in murine macrophages.
    Rao P; Falk LA; Dougherty SF; Sawada T; Pluznik DH
    J Immunol; 1997 Oct; 159(7):3531-9. PubMed ID: 9317152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
    Gabizon A; Leibovich SJ; Goldman R
    J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine.
    Calderon CL; Torroella-Kouri M; Dinapoli MR; Lopez DM
    Int J Oncol; 2008 Mar; 32(3):713-21. PubMed ID: 18292949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of titanium surface topography on macrophage activation and secretion of proinflammatory cytokines and chemokines.
    Refai AK; Textor M; Brunette DM; Waterfield JD
    J Biomed Mater Res A; 2004 Aug; 70(2):194-205. PubMed ID: 15227664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of a tumor cytolytic factor(s) by activated human alveolar macrophages and its action.
    Sone S; Tachibana K; Ishii K; Ogawara M; Tsubura E
    Cancer Res; 1984 Feb; 44(2):646-51. PubMed ID: 6692369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Production of a cytotoxic factor in mouse peritoneal fluid by OK-432, a streptococcal preparation].
    Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
    Gan To Kagaku Ryoho; 1986 May; 13(5):1905-10. PubMed ID: 3707150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purified human macrophage secretions suppress tumor growth in the mouse.
    Cameron DJ
    J Reticuloendothel Soc; 1983 Jul; 34(1):45-52. PubMed ID: 6410064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of LPS-mediated cell activation in vitro and in vivo by gangliosides.
    Mond JJ; Witherspoon K; Yu RK; Perera PY; Vogel SN
    Circ Shock; 1994 Oct; 44(2):57-62. PubMed ID: 7743601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo cisplatin-exposed macrophages increase immunostimulant-induced nitric oxide synthesis for tumor cell killing.
    Son K; Kim YM
    Cancer Res; 1995 Dec; 55(23):5524-7. PubMed ID: 7585626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of peritoneal cells on tumors cells growth in vitro.
    Salwa J
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):37-41. PubMed ID: 8744682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.